首页 | 官方网站   微博 | 高级检索  
     


Value assessment of oncology drugs using a weighted criterion-based approach
Authors:Doreen A Ezeife MD  Francois Dionne PhD  Aline Fusco Fares MD  Ellen Laura Rose Cusano MD  Rouhi Fazelzad BSc  MISt  Wenzie Ng BSc  MPharm  RPh  Don Husereau BSc Pharm  MSc  Farzad Ali BPharm  MSc  Christina Sit MSc  Barry Stein BCom BCL  LLB  Jennifer H Law MSc  Lisa Le MSc  Peter Michael Ellis MD  MMed  PhD  Scott Berry MD  Stuart Peacock PhD  Craig Mitton PhD  Craig C Earle MD  Kelvin K W Chan MD  PhD  Natasha B Leighl MD  MMSc
Affiliation:1. Department of Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada;2. Prioritize Consulting Ltd, Vancouver, British Columbia, Canada;3. Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada;4. Department of Medical Oncology and Hematology, Library and Information Services, Princess Margaret Cancer Centre, Toronto, Ontario, Canada;5. School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada;6. Pfizer Inc, New York, New York;7. Lung Cancer Canada, Toronto, Ontario, Canada;8. Colorectal Cancer Canada, Montreal, Quebec, Canada;9. Juravinski Cancer Centre, Hamilton, Ontario, Canada;10. Cancer Centre of Southeastern Ontario, Kingston, Ontario, Canada;11. British Columbia Cancer Agency, Vancouver, British Columbia, Canada;12. The University of British Columbia, Vancouver, British Columbia, Canada;13. Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada
Abstract:
Keywords:anticancer therapy  multicriteria decision analysis  value assessment  value assessment framework
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号